Mkts

RxSight, Inc.

NASDAQ: RXST
$5.01+0.18 (+3.73%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
4.805.07
52-week range
4.1113.22
Today
Open4.82
Previous close5.01
Volume616.7K
Valuation
Market cap210.07M
P/E ratio—
EPS (TTM)-1.29
Income & risk
Dividend / yield—
Beta1.21
Avg volume870.5K
Discussion

RXST News

Stories mentioning RXST from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue30,89332,60730,34033,63737,89540,21435,31434,887
Cost of Goods Sold7,3957,3446,1138,4479,56611,42610,09410,637
Gross Profit23,49825,26324,22725,19028,32928,78825,22024,250
Operating Expenses
Research & Development9,4728,9059,06010,21710,3679,2078,8388,291
Sales General & Admin31,85527,69427,34528,97628,63628,21025,60824,292
Total Operating Expenses41,32736,59936,40539,19339,00337,41734,44632,583
Operating Income (Loss)(17,829)(11,336)(12,178)(14,003)(10,674)(8,629)(9,226)(8,333)
Interest Income
Interest Expense3.004.004.005.006.004.005.006.00
Other Expense
Pretax Income(15,878)(9,146)(9,806)(11,754)(8,172)(5,926)(6,325)(6,063)
Tax Provision6.006.0010.0032.0018.0012.0013.0016.00
Net Income (Loss)(15,884)(9,152)(9,816)(11,786)(8,190)(5,938)(6,338)(6,079)
Earnings Per Share (Basic)(0.38)(0.22)(0.24)(0.29)(0.20)(0.15)(0.16)(0.16)
Earnings Per Share (Diluted)(0.38)(0.22)(0.24)(0.29)(0.20)(0.15)(0.16)(0.16)
Weighted Average Shares Outstanding (Basic)41,30640,85140,96540,74440,51038,86839,78938,456
Weighted Average Shares Outstanding (Diluted)41,30640,85140,96540,74440,51038,86839,78938,456

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About RXST

RxSight, Inc. (NASDAQ: RXST) is a stock listed on the Nasdaq Stock Market under the ticker symbol RXST. It last traded at $5.01 (Nov 18, 2026, 4:00 PM ET), up 3.7% on the day. That gives RxSight a market capitalisation of $210.1M.

Over the past 52 weeks RXST has traded between $4.11 and $13.22.

Revenue for the quarter ended Mar 31, 2026 was $30.9M; a net loss of $15.9M. Revenue was down 18.5% from $37.9M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$30.9M-$15.9M-51.4%
Dec 31, 2025$32.6M-$9.2M-28.1%
Sep 30, 2025$30.3M-$9.8M-32.4%
Jun 30, 2025$33.6M-$11.8M-35.0%

From RxSight’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…